Olga Rafikova

Interests

No activities entered.

Courses

Scholarly Contributions

Journals/Publications

• Rafikov, R., Rafikova, O., Langlais, P. R., Mandarino, L. J., Luo, M., Barker, N. K., Niihori, M., Varghese, M. V., Eccles, C. A., Zemskova, M., & James, J. (2021). Single Mutation in the NFU1 Gene Metabolically Reprograms Pulmonary Artery Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology.
• James, J., Srivastava, A., Varghese, M. V., Eccles, C. A., Zemskova, M., Rafikova, O., & Rafikov, R. (2020). Heme induces rapid endothelial barrier dysfunction via the MKK3/p38MAPK axis. Blood, 136(6), 749-754.
  More info

  Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome, and sepsis. However, the precise molecular mechanisms involved in the pathology of heme-induced barrier disruption remain to be elucidated. In this study, we investigated the role of free heme in the endothelial barrier integrity and mechanisms of heme-mediated intracellular signaling of human lung microvascular endothelial cells (HLMVECs). Heme, in a dose-dependent manner, induced a rapid drop in the endothelial barrier integrity of HLMVECs. An investigation into barrier proteins revealed that heme primarily affected the tight junction proteins zona occludens-1, claudin-1, and claudin-5, which were significantly reduced after heme exposure. The p38MAPK/HSP27 pathway, involved in the regulation of endothelial cytoskeleton remodeling, was also significantly altered after heme treatment, both in HLMVECs and mice. By using a knockout (KO) mouse for MKK3, a key regulator of the p38MAPK pathway, we showed that this KO effectively decreased heme-induced endothelial barrier dysfunction. Taken together, our results indicate that targeting the p38MAPK pathway may represent a crucial treatment strategy in alleviating hemolytic diseases.
• James, J., Valuparampil Varghese, M., Vasilyev, M., Langlais, P. R., Tofovic, S. P., Rafikova, O., & Rafikov, R. (2020). Complex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape. International journal of molecular sciences, 21(16).
  More info

  The mitochondria play a vital role in controlling cell metabolism and regulating crucial cellular outcomes. We previously demonstrated that chronic inhibition of the mitochondrial complex III in rats by Antimycin A (AA) induced sustained pulmonary vasoconstriction. On the metabolic level, AA-induced mitochondrial dysfunction resulted in a glycolytic shift that was reported as the primary contributor to pulmonary hypertension pathogenesis. However, the regulatory proteins driving this metabolic shift with complex III inhibition are yet to be explored. Therefore, to delineate the mechanisms, we followed changes in the rat lung mitochondrial proteome throughout AA treatment. Rats treated with AA for up to 24 days showed a disturbed mitochondrial proteome with significant changes in 28 proteins ( < 0.05). We observed a time-dependent decrease in the expression of key proteins that regulate fatty acid oxidation, the tricarboxylic acid cycle, the electron transport chain, and amino acid metabolism, indicating a correlation with diminished mitochondrial function. We also found a significant dysregulation in proteins that controls the protein import machinery and the clearance and detoxification of oxidatively damaged peptides via proteolysis and mitophagy. This could potentially lead to the onset of mitochondrial toxicity due to misfolded protein stress. We propose that chronic inhibition of mitochondrial complex III attenuates mitochondrial function by disruption of the global mitochondrial metabolism. This potentially aggravates cellular proliferation by initiating a glycolytic switch and thereby leads to pulmonary hypertension.
• James, J., Zemskova, M., Eccles, C. A., Varghese, M. V., Niihori, M., Barker, N. K., Luo, M., Mandarino, L. J., Langlais, P. R., Rafikova, O., & Rafikov, R. (2020). Single Mutation in the Gene Metabolically Reprograms Pulmonary Artery Smooth Muscle Cells. Arteriosclerosis, thrombosis, and vascular biology, ATVBAHA120314655.
  More info

  NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation NFU1 and CRISPR/CAS9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat-associated 9)-generated rats develop mitochondrial dysfunction leading to pulmonary arterial hypertension. However, the mechanistic understanding of pulmonary vascular proliferation due to a single mutation in NFU1 remains unresolved. Approach and Results: Quantitative proteomics of isolated mitochondria showed the entire phenotypic transformation of NFU1 rats with a disturbed mitochondrial proteomic landscape, involving significant changes in the expression of 208 mitochondrial proteins. The NFU1 mutation deranged the expression pattern of electron transport proteins, resulting in a significant decrease in mitochondrial respiration. Reduced reliance on mitochondrial respiration amplified glycolysis in pulmonary artery smooth muscle cell (PASMC) and activated GPD (glycerol-3-phosphate dehydrogenase), linking glycolysis to oxidative phosphorylation and lipid metabolism. Decreased PDH (pyruvate dehydrogenase) activity due to the lipoic acid shortage is compensated by increased fatty acid metabolism and oxidation. PASMC became dependent on extracellular fatty acid sources due to upregulated transporters such as CD36 and CPT (carnitine palmitoyltransferase)-1. Finally, the NFU1 mutation produced a dysregulated antioxidant system in the mitochondria, leading to increased reactive oxygen species levels. PASMC from NFU1 rats showed apoptosis resistance, increased anaplerosis, and attained a highly proliferative phenotype. Attenuation of mitochondrial reactive oxygen species by mitochondrial-targeted antioxidant significantly decreased PASMC proliferation.
• Mohamed, R., Rafikova, O., O'Connor, P. M., & Sullivan, J. C. (2020). Greater high-mobility group box 1 in male compared with female spontaneously hypertensive rats worsens renal ischemia-reperfusion injury. Clinical science (London, England : 1979), 134(13), 1751-1762.
  More info

  Renal ischemia is the most common cause of acute kidney injury. Damage-associated molecular patterns (DAMPs) initiate an inflammatory response and contribute to ischemia-reperfusion (IR) injury in males, yet the contribution of DAMPs to IR injury in females is unknown. The goal of the current study was to test the hypothesis that males have greater increases in the DAMP high-mobility group box 1 (HMGB1), worsening injury compared with females. Thirteen-week-old male and female spontaneously hypertensive rats (SHR) were subjected to sham or 45-min warm bilateral ischemia followed by 24 h of reperfusion before measurement of HMGB1 and renal function. Additional SHR were pre-treated with control (IgG) or HMGB1 neutralizing antibody (300 µg/rat) 1 h prior to renal ischemia. Blood, urine and kidneys were harvested 24 h post-IR for histological and Western blot analyses. Initial studies confirmed that IR resulted in greater increases in renal HMGB1 in male SHR compared with females. Greater renal HMGB1 in male SHR post-IR resulted in greater increases in serum TNF-α and renal IL-1β, neutrophil infiltration and tubular cell death. Neutralization of HMGB1 attenuated IR-induced increases in plasma creatinine, blood urea nitrogen (BUN), inflammation, tubular damage and tubular cell death only in male SHR. In conclusion, our data demonstrate that there is a sex difference in the contribution of HMGB1 to IR-induced injury, where males exhibit greater increases in HMGB1-mediated renal injury in response to IR compared with females.
• Niihori, M., Eccles, C. A., Kurdyukov, S., Zemskova, M., Varghese, M. V., Stepanova, A. A., Galkin, A., Rafikov, R., & Rafikova, O. (2020). Rats with a Human Mutation of NFU1 Develop Pulmonary Hypertension. American journal of respiratory cell and molecular biology, 62(2), 231-242.
  More info

  NFU1 is a mitochondrial protein that is involved in the biosynthesis of iron-sulfur clusters, and its genetic modification is associated with disorders of mitochondrial energy metabolism. Patients with autosomal-recessive inheritance of the NFU1 mutation G208C have reduced activity of the respiratory chain Complex II and decreased levels of lipoic-acid-dependent enzymes, and develop pulmonary arterial hypertension (PAH) in ∼70% of cases. We investigated whether rats with a human mutation in NFU1 are also predisposed to PAH development. A point mutation in rat NFU1 (human G208C) was introduced through CRISPR/Cas9 genome editing. Hemodynamic data, tissue samples, and fresh mitochondria were collected and analyzed. NFU1 rats showed increased right ventricular pressure, right ventricular hypertrophy, and high levels of pulmonary artery remodeling. Computed tomography and angiography of the pulmonary vasculature indicated severe angioobliterative changes in NFU1 rats. Importantly, the penetrance of the PAH phenotype was found to be more prevalent in females than in males, replicating the established sex difference among patients with PAH. Male and female homozygote rats exhibited decreased expression and activity of mitochondrial Complex II, and markedly decreased pyruvate dehydrogenase activity and lipoate binding. The limited development of PAH in males correlated with the preserved levels of oligomeric NFU1, increased expression of ISCU (an alternative branch of the iron-sulfur assembly system), and increased complex IV activity. Thus, the male sex has additional plasticity to overcome the iron-sulfur cluster deficiency. Our work describes a novel, humanized rat model of NFU1 deficiency that showed mitochondrial dysfunction similar to that observed in patients and developed PAH with the same sex dimorphism.
• Rafikov, R., Coletta, D. K., Mandarino, L. J., & Rafikova, O. (2020). Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites. Journal of clinical medicine, 9(1).
  More info

  Pulmonary arterial hypertension (PAH) is an incurable, progressive disorder, and the early diagnosis and treatment of PAH are associated with increased survival [...].
• Rafikov, R., Rafikova, O., Tofovic, S. P., Langlais, P. R., Vasilyev, M., Varghese, M. V., & James, J. (2020). Complex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape. International Journal of Molecular Sciences.
• Rafikova, O., James, J., Eccles, C. A., Kurdyukov, S., Niihori, M., Varghese, M. V., & Rafikov, R. (2020). Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability. Biology of sex differences, 11(1), 11.
  More info

  The mechanisms involved in pulmonary hypertension (PH) development in patients and pre-clinical models are poorly understood. PH has a well-established sex dimorphism in patients with increased frequency of PH in females, and more severe disease with poor survival prognosis in males. Previously, we found that heme signaling plays an essential role in the development phase of the Sugen/Hypoxia (SU/Hx) model. This study is focused on the elucidation of sex differences in mechanisms of PH development related to heme action at the early stage of the monocrotaline (MCT) PH model.
• Valuparampil Varghese, M., James, J., Eccles, C. A., Niihori, M., Rafikova, O., & Rafikov, R. (2020). Inhibition of Anaplerosis Attenuated Vascular Proliferation in Pulmonary Arterial Hypertension. Journal of clinical medicine, 9(2).
  More info

  Vascular remodeling is considered a key event in the pathogenesis of pulmonary arterial hypertension (PAH). However, mechanisms of gaining the proliferative phenotype by pulmonary vascular cells are still unresolved. Due to well-established pyruvate dehydrogenase (PDH) deficiency in PAH pathogenesis, we hypothesized that the activation of another branch of pyruvate metabolism, anaplerosis, via pyruvate carboxylase (PC) could be a key contributor to the metabolic reprogramming of the vasculature. In sugen/hypoxic PAH rats, vascular proliferation was found to be accompanied by increased activation of Akt signaling, which upregulated membrane Glut4 translocation and caused upregulation of hexokinase and pyruvate kinase-2, and an overall increase in the glycolytic flux. Decreased PDH activity and upregulation of PC shuttled more pyruvate to oxaloacetate. This results in the anaplerotic reprogramming of lung vascular cells and their subsequent proliferation. Treatment of sugen/hypoxia rats with the PC inhibitor, phenylacetic acid 20 mg/kg, starting after one week from disease induction, significantly attenuated right ventricular systolic pressure, Fulton index, and pulmonary vascular cell proliferation. PC inhibition reduced the glycolytic shift by attenuating Akt-signaling, glycolysis, and restored mitochondrial pyruvate oxidation. Our findings suggest that targeting PC mediated anaplerosis is a potential therapeutic intervention for the resolution of vascular remodeling in PAH.
• Varghese, M. V., Niihori, M., Eccles, C. A., Kurdyukov, S., James, J., Rafikova, O., & Rafikov, R. (2020). Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension. Antioxidants (Basel, Switzerland), 9(2).
  More info

  Pulmonary arterial hypertension (PAH) is a chronic cardiopulmonary disorder instigated by pulmonary vascular cell proliferation. Activation of Akt was previously reported to promote vascular remodeling. Also, the irreversible nitration of Y350 residue in Akt results in its activation. NitroAkt was increased in PAH patients and the SU5416/Hypoxia (SU/Hx) PAH model. This study investigated whether the prevention of Akt nitration in PAH by Akt targeted nitroxide-conjugated peptide (NP) could reverse vascular remodeling and metabolic reprogramming. Treatment of the SU/Hx model with NP significantly decreased nitration of Akt in lungs, attenuated right ventricle (RV) hypertrophy, and reduced RV systolic pressure. In the PAH model, Akt-nitration induces glycolysis by activation of the glucose transporter Glut4 and lactate dehydrogenase-A (LDHA). Decreased G6PD and increased GSK3β in SU/Hx additionally shunted intracellular glucose via glycolysis. The increased glycolytic rate upregulated anaplerosis due to activation of pyruvate carboxylase in a nitroAkt-dependent manner. NP treatment resolved glycolytic switch and activated collateral pentose phosphate and glycogenesis pathways. Prevention of Akt-nitration significantly controlled pyruvate in oxidative phosphorylation by decreasing lactate and increasing pyruvate dehydrogenases activities. Histopathological studies showed significantly reduced pulmonary vascular proliferation. Based on our current observation, preventing Akt-nitration by using an Akt-targeted nitroxide-conjugated peptide could be a useful treatment option for controlling vascular proliferation in PAH.
• Zemskova, M. A., Rafikova, O., Rafikov, R., Mcclain, N., Kurdyukov, S., & James, J. (2020). S1 Raw images. PLOS ONE. doi:10.1371/journal.pone.0231267.s001
• Zemskova, M. A., Varghes, M. V., Rafikova, O., Rafikov, R., & James, J. (2020). Abstract 17211: Targeting Mitogen-Activated Kinase Alleviates Free Heme-Induced Endothelial Barrier Dysfunction and Vascular Leakage in Lungs. Circulation, 142. doi:10.1161/circ.142.suppl_3.17211
  More info

  Introduction: Several studies confirm that free heme in circulation due to hemolysis causes endothelial barrier dysfunction. We recently demonstrated that hemolysis-induced vascular leakage with ba...
• Zemskova, M., Kurdyukov, S., James, J., McClain, N., Rafikov, R., & Rafikova, O. (2020). Sex-specific stress response and HMGB1 release in pulmonary endothelial cells. PloS one, 15(4), e0231267.
  More info

  Women are known to be associated with a higher susceptibility to pulmonary arterial hypertension (PAH). In contrast, male PAH patients have a worse survival prognosis. In this study, we investigated whether the contribution of sex goes beyond the effects of sex hormones by comparing the ability of isolated male and female pulmonary endothelial cells to respire, proliferate and tolerate the stress. Mouse lung endothelial cells (MLEC) were isolated from the lungs of male and female 3-week old mice. Male MLEC showed an increased basal mitochondrial respiration rate, elevated maximal respiration, a significantly greater level of mitochondrial polarization, and a higher rate of proliferation. Exposure of cells to hypoxia (2% of O2 for 24 hours) induced a strong apoptotic response in female but not male MLEC. In contrast, treatment with mitochondrial respiratory Complex III inhibitor Antimycin A (AA, 50μM) mediated severe necrosis specifically in male MLEC, while female cells again responded primarily by apoptosis. The same effect with female cells responding to the stress by apoptosis and male cells responding by necrosis was confirmed in starved pulmonary endothelial cells isolated from human donors. Elevated necrosis seen in male cells was associated with a significant release of damage-associated alarmin, HMGB1. No stimuli induced a significant elevation of HMGB1 secretion in females. We conclude that male cells appear to be protected against mild stress conditions, such as hypoxia, possibly due to increased mitochondrial respiration. In contrast, they are more sensitive to impaired mitochondrial function, to which they respond by necrotic death. Necrosis in male vascular cells releases a significant amount of HMGB1 that could contribute to the pro-inflammatory phenotype known to be associated with the male gender.
• Zemskova, M., McClain, N., Niihori, M., Varghese, M. V., James, J., Rafikov, R., & Rafikova, O. (2020). Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex. Hypertension (Dallas, Tex. : 1979), 76(6), 1787-1799.
  More info

  Damage-associated molecular patterns, such as HMGB1 (high mobility group box 1), play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary vasculature. However, the contribution of the particular type of vascular cells, type of cell death, or the form of released HMGB1 in PAH remains unclear. Moreover, although male patients with PAH show a higher level of circulating HMGB1, its involvement in the severe PAH phenotype reported in males is unknown. In this study, we aimed to investigate the sources and active forms of HMGB1 released from damaged vascular cells and their contribution to the progressive type of PAH in males. Our results showed that HMGB1 is released by either pulmonary artery human endothelial cells or human pulmonary artery smooth muscle cells that underwent necrotic cell death, although only human pulmonary artery smooth muscle cells produce HMGB1 during apoptosis. Moreover, only human pulmonary artery smooth muscle cell death induced a release of dimeric HMGB1, found to be mitochondrial reactive oxygen species dependent, and TLR4 (toll-like receptor 4) activation. The modified Sugen/Hypoxia rat model replicates the human sexual dimorphism in PAH severity (right ventricle systolic pressure in males versus females 54.7±2.3 versus 44.6±2 mm Hg). By using this model, we confirmed that necroptosis and necrosis are the primary sources of circulating HMGB1 in the male rats, although only necrosis increased circulation of HMGB1 dimers. Attenuation of necrosis but not apoptosis or necroptosis prevented TLR4 activation in males and blunted the sex differences in PAH severity. We conclude that necrosis, through the release of HMGB1 dimers, predisposes males to a progressive form of PAH.
• Abdelbary, M., Rafikova, O., Gillis, E. E., Musall, J. B., Baban, B., O'Connor, P. M., Brands, M. W., & Sullivan, J. C. (2019). Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats. Hypertension (Dallas, Tex. : 1979), 74(6), 1524-1531.
  More info

  Necrosis is a pathological form of cell death that induces an inflammatory response, and immune cell activation contributes to the development and maintenance of hypertension. Necrosis was measured in kidney, spleen, and aorta of 12- to 13-week-old male and female SHRs (spontaneously hypertensive rats); male SHRs had greater renal necrotic cell death than female SHRs. Because male SHRs have a higher blood pressure (BP) and a more proinflammatory T-cell profile than female SHRs, the current studies tested the hypothesis that greater necrotic cell death in male SHRs exacerbates increases in BP and contributes to the proinflammatory T-cell profile. Male and female SHRs were randomized to receive vehicle or Necrox-5-a cell permeable inhibitor of necrosis-from 6 to 12 weeks of age or from 11 to 13 weeks of age. In both studies, Necrox-5 decreased renal necrosis and abolished the sex difference. Treatment with Necrox-5 beginning at 6 weeks of age attenuated maturation-induced increases in BP in male SHR; BP in female SHR was not altered by Necrox-5 treatment. Necrox-5 decreased proinflammatory renal T cells in both sexes, although sex differences were maintained. Administration of Necrox-5 for 2 weeks in SHR with established hypertension resulted in a small but significant decrease in BP in males with no effect in females. These results suggest that greater necrotic cell death in male SHR exacerbates maturation-induced increases in BP with age contributing to sex differences in BP. Moreover, although necrosis is proinflammatory, it is unlikely to explain sex differences in the renal T-cell profile.
• Abdelbary, M., Rafikova, O., Gillis, E. E., Musall, J. B., Baban, B., O’Connor, P. M., Brands, M. W., & Sullivan, J. C. (2019). Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats. Hypertension.
• Niihori, M., Eccles, C., Kurdyujov, S., Zemskova, M., Varghese, M. V., Stepanova, A. A., Galkin, A., Rafikov, R., & Rafikova, O. (2019). Rats with Human Mutation of NFU1 Develop Pulmonary Hypertension. Am J Respir Cell Mol Biol.
• Rafikov, R., James, J., McClain, N., Tofovic, S. P., & Rafikova, O. (2019). Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension. Antioxidants (Basel, Switzerland), 8(5).
  More info

  Pulmonary arterial hypertension (PAH) is one of the diseases with a well-established gender dimorphism. The prevalence of PAH is increased in females with a ratio of 4:1, while poor survival prognosis is associated with the male gender. Nevertheless, the specific contribution of gender in disease development and progression is unclear due to the complex nature of the PAH. Oxidative and nitrosative stresses are important contributors in PAH pathogenesis; however, the role of gender in redox homeostasis has been understudied. This review is aimed to overview the possible sex-specific mechanisms responsible for the regulation of the balance between oxidants and antioxidants in relation to PAH pathobiology.
• Rafikov, R., James, J., McClain, N., Tofovic, S. S., & Rafikova, O. (2019). Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension. Antioxidants.
• Rafikov, R., McBride, M. L., Zemskova, M., Kurdyukov, S., McClain, N., Niihori, M., Langlais, P. R., & Rafikova, O. (2019). INOSITOL MONOPHOSPHATASE 1 (IMPA1) AS A NOVEL INTERACTING PARTNER OF RAGE IN PULMONARY HYPERTENSION. American journal of physiology. Lung cellular and molecular physiology.
  More info

  Pulmonary arterial hypertension (PAH) is a lethal disease characterized by progressive pulmonary vascular remodeling. The receptor for advanced glycation endproducts (RAGE) plays an important role in PAH by promoting proliferation of pulmonary vascular cells. RAGE is also known to mediate activation of Akt signaling, although the particular molecular mechanism remains unknown. This study aimed to identify the interacting partner of RAGE that could facilitate RAGE-mediated Akt activation and vascular remodeling in PAH. The progressive angioproliferative PAH was induced in 24 female Sprague-Dawley rats (n=8/group) that were randomly assigned to develop PAH for one, two or five weeks (right ventricle peak systolic pressure (RVPSP) 56.5±3.2mmHg, 63.6±1.6mmHg and 111.1±4.5mmHg respectively vs. 22.9±1.1mmHg in Controls). PAH triggered early and late episodes of apoptosis in rat lungs accompanied by RAGE activation. Mass spectrometry analysis has identified IMPA1 as a novel PAH-specific interacting partner of RAGE. The proximity ligation assay (PLA) confirmed the formation of RAGE/IMPA1 complex in the pulmonary artery wall. Activation of IMPA1 in response to increased glucose-6-phosphate (G6P) is known to play a critical role in inositol synthesis and recycling. Indeed, we confirmed a 3-fold increase of G6P (p=0.0005) levels in lungs of PAH rats starting from week 1 that correlated with accumulation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), membrane translocation of PI3K, and a 3-fold increase in membrane Akt levels (p=0.02) and Akt phosphorylation. We conclude that the formation of the newly discovered RAGE/IMPA1 complex could be responsible for the stimulation of inositol pathways and activation of Akt signaling in PAH.
• Rafikov, R., Nair, V., Sinari, S., Babu, H., Sullivan, J. C., Yuan, J. X., Desai, A. A., & Rafikova, O. (2019). Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension. Antioxidants & redox signaling, 31(13), 917-932.
  More info

  Pulmonary arterial hypertension (PAH) is a progressive lethal disease with a known gender dimorphism. Female patients are more susceptible to PAH, whereas male patients have a lower survival rate. Initial pulmonary vascular damage plays an important role in PAH pathogenesis. Therefore, this study aimed at investigating the role of gender in activation of apoptosis/necrosis-mediated signaling pathways in PAH. The media collected from pulmonary artery endothelial cells (PAECs) that died by necrosis or apoptosis were used to treat naive PAECs. Necrotic cell death stimulated phosphorylation of toll-like receptor 4, accumulation of interleukin 1 beta, and expression of E-selectin in a redox-dependent manner; apoptosis did not induce any of these effects. In the animal model of severe PAH, the necrotic marker, high mobility group box 1 (HMGB1), was visualized in the pulmonary vascular wall of male but not female rats. This vascular necrosis was associated with male-specific redox changes in plasma, activation of the same inflammatory signaling pathway seen in response to necrosis , and an increased endothelial-leukocyte adhesion in small pulmonary arteries. In PAH patients, gender-specific changes in redox homeostasis correlated with the prognostic marker, B-type natriuretic peptide. Males had also shown elevated circulating levels of HMGB1 and pro-inflammatory changes. This study discovered the role of gender in the initiation of damage-associated signaling in PAH and highlights the importance of the gender-specific approach in PAH therapy. In PAH, the necrotic cell death is augmented in male patients compared with female patients. Factors released from necrotic cells could alter redox homeostasis and stimulate inflammatory signaling pathways.
• Rafikov, R., Nair, V., Sinari, S., Babu, H., Sullivan, J., Yuan, J., Desai, A., & Rafikova, O. (2019). Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension. Antioxidant Redox Signaling.
• Rafikova, O., Al Ghouleh, I., & Rafikov, R. (2019). Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development. Antioxidant Redox Signaling.
• Rafikova, O., Al Ghouleh, I., & Rafikov, R. (2019). Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development. Antioxidants & redox signaling, 31(13), 933-953.
  More info

  Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vasculature characterized by the proliferation of all vascular wall cell types, including endothelial, smooth muscle, and fibroblasts. The disease rapidly advances into a form with extensive pulmonary vascular remodeling, leading to a rapid increase in pulmonary vascular resistance, which results in right heart failure. Most current research in the PAH field has been focused on the late stage of the disease, largely due to an urgent need for patient treatment options in clinics. Further, the pathobiology of PAH is multifaceted in the advanced disease, and there has been promising recent progress in identifying various pathological pathways related to the late clinical picture. Early stage PAH still requires additional attention from the scientific community, and although the survival of patients with early diagnosis is comparatively higher, the disease develops in patients asymptomatically, making it difficult to identify and treat early. There are several reasons to focus on the early stage of PAH. First, the complexity of late stage disease, owing to multiple pathways being activated in a complex system with intra- and intercellular signaling, leads to an unclear picture of the key contributors to the pathobiology. Second, an understanding of early pathophysiological events can increase the ability to identify PAH patients earlier than what is currently possible. Third, the prompt diagnosis of PAH would allow for the therapy to start earlier, which has proved to be a more successful strategy, and it ensures better survival in PAH patients.
• Rafikova, O., Langlais, P. R., Niihori, M., McClain, N., Kurdyukov, S., Zemskova, M., McBride, M. L., & Rafikov, R. (2019). INOSITOL MONOPHOSPHATASE 1 (IMPA1) AS A NOVEL INTERACTING PARTNER OF RAGE IN PULMONARY HYPERTENSION.. American Journal of Physiology - Lung Cellular and Molecular Physiology.
• Gillis, E. E., Brinson, K. N., Rafikova, O., Chen, W., Musall, J. B., Harrison, D. G., & Sullivan, J. C. (2018). Oxidative stress induces BH deficiency in male, but not female, SHR. Bioscience reports, 38(4).
  More info

  We previously published that female spontaneously hypertensive rats (SHR) have significantly greater nitric oxide (NO) bioavailability and NO synthase (NOS) enzymatic activity in the renal inner medulla (IM) compared with age-matched males, although the mechanism responsible remains unknown. Tetrahydrobiopterin (BH) is a critical cofactor required for NO generation, and decreases in BH as a result of increases in oxidative stress have been implicated in the pathogenesis of hypertension. As male SHR are known to have higher levels of oxidative stress compared with female SHR, we hypothesized that relative BH deficiency induced by oxidative stress in male SHR results in lower levels of NOS activity in renal IM compared with females. Twelve-week-old male and female SHR were randomized to receive tempol (30 mg/kg/day via drinking water) or vehicle for 2 weeks. Tempol treatment did not affect blood pressure (BP) in either sex, but reduced peroxynitrite levels only in males. Females had more total biopterin, dihydrobiopterin (BH), and BH levels in renal IMs than males, and tempol treatment eliminated these sex differences. Females had greater total NOS activity in the renal IM than males, and adding exogenous BH to the assay increased NOS activity in both sexes. This sex difference in total NOS and the effect of exogenous BH were abolished with tempol treatment. We conclude that higher oxidative stress in male SHR results in a relative deficiency of BH compared with females, resulting in diminished renal NOS activity in the male.
• Kurdyukov, S., Eccles, C. A., Desai, A. A., Gonzalez-Garay, M., Yuan, J. X., Garcia, J. G., Rafikova, O., & Rafikov, R. (2018). New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension. PloS one, 13(8), e0203493.
  More info

  Pulmonary Arterial Hypertension (PAH) is a fatal disorder with limited treatment options and reduced life expectancy after diagnosis. Complex genetic backgrounds in PAH complicates identification of causative mutations that is essential for an understanding of the disease diagnostics and etiology especially for idiopathic PAH (iPAH). Hemolysis has been implicated as contributing to the pathobiology of PAH. Glucose-6-Phosphate Dehydrogenase (G6PD) expression and activity define erythrocyte's antioxidant capacity, and its decrease contributes to erythrocyte fragility. As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes. A cohort of 22 PAH patients and 8 non-PAH patients were recruited for this study. DNA isolated from Peripheral Blood Mononuclear Cells (PBMC) was used for detection of mutations in the coding region of the G6PD gene. RNA isolated from PBMC was used for determination of G6PD mRNA expression level. G6PD activity was measured in Red Blood Cell (RBC) pellets. Three patients had missense mutations in G6PD (Val291Met, Asn126Asp, Asp194Glu), however, only one mutation (Val291Met) results in a severe G6PD deficiency. A single patient with mutation (Asn126Asp) showed a 21% decrease in G6PD activity, two subjects showed G6PD deficiency without mutations, and one patient had a decreased level of G6PD mRNA and reduced enzyme levels. This study demonstrates that a moderate decrease in G6PD activity is associated with PAH. Screening for G6PD activity and mutations in the G6PD gene may provide early detection of individuals predisposed to PAH.
• Langlais, P., Vasilyev, M., Tofovic, S. P., Rafikova, O., Rafikov, R., Langlais, P. R., & Eccles, C. A. (2018). Inhibition of respiratory chain Complex III irreversibly changes the mitochondria proteomic landscape. Free Radical Biology and Medicine, 128, S91-S92. doi:10.1016/j.freeradbiomed.2018.10.214
  More info

  The role of mitochondria dysfunction in the pathogenesis of pulmonary hypertension (PH) is currently well-recognized. However, the particular mechanisms and the type of mitochondrial dysfunction are still being debated. We have recently shown that chronic inhibition of oxidative phosphorylation by Antimycin A (AA) results in increased pulmonary pressure and remodeled pulmonary arteries. AA (0.35mg/kg) was given to rats three times during first six days and lungs were analyzed 30 minutes (acute effect), 12 and 24 days (chronic effect) after the first AA injection. Mitochondria isolated from lungs were subjected to mass spectrometry and quantitative proteomic analysis to estimate changes in the isolated mitochondrial proteome over the course of disease development. Using a 4-fold change cutoff value, 48 mitochondrial proteins were discovered to be altered upon AA treatment, with 13 proteins exhibiting a significant difference. Our data indicate that proteomic data with applied 4-fold cutoff can completely distinguish between the control and 24-day groups using principal component analysis. Functional analysis of the proteome data revealed major downregulation of enzymes involved in fatty acids oxidation(ACDSB,HADH) and fatty acids transport(CPT1, ACSM5). Electron transport chain proteins showed mixed results with downregulation of Complex IV (COX1/2), altered Complex I subunits(NU4/5M) and assembly protein expression(NDUF4), and upregulation of ubiquinone biosynthesis (COQ3/7). Activation of ubiquinone biosynthesis could be explained as compensation for inhibition of mitochondrial respiration by AA. Mitochondrial machinery for importing proteins into the matrix(TIM9/10/13) was upregulated, but peptidases(LON,MPPA) that control the quality of matrix proteins were downregulated. Finally, proteins that regulate mitochondria morphology(MIRO2, PGAM5,TMM11) and degradation pathways (MIEAP,BCL2) were altered. Collectively, our data indicate that chronic inhibition of the respiratory chain for six days leads to irreversible changes in the proteomic landscape of mitochondria. These changes reprogram mitochondria to a different metabolic state and altered morphology that have been found in various models of PH and PH patients.
• Niihori, M., Zemskova, M. A., Rafikova, O., Rafikov, R., Niihori, M., & Eccles, C. A. (2018). Pulmonary hypertension in rats with human mutation of NFU1 is oxygen sensitive. Free Radical Biology and Medicine, 128, S34. doi:10.1016/j.freeradbiomed.2018.10.041
  More info

  Mitochondrial dysfunction is known to be directly associated with the pathogenesis of pulmonary hypertension (PH). NFU1 is an important mitochondrial protein involved in [4Fe-4S] cluster biogenesis and incorporation of newly synthesized [4Fe-4S] clusters into the target proteins. Patients with autosome recessive inheritance of NFU1 mutation c.622G>T have the reduced activity of respiratory chain complex II, lipoic-acid dependent enzymes and develop pulmonary hypertension (PH) in ~ 70% of cases. In this study, we analyzed the genetic rat model that reproduces the human mutation of NFU1. The penetrance of pulmonary hypertension in homozygote NFU1G206C rats was found to be 73% in females and only 22% in males. Both genders showed a significantly reduced complex II and PHD activity. However, while in females the expression of both complex II subunits (SDHA and SDHB) was significantly impaired, males showed a decreased expression of SDHA only. The limited development of PH in males also correlated with an increased expression of another Fe-S scaffold protein, ISCU. This protection was not evident in female rats. The previous research showed a critical role of NFU1 in the protection of [4Fe-4S] clusters against oxidation. The inhibition of complex II in NFU1 knockouts occurred only in the presence of oxygen (in normoxia) but not in anoxia. We confirmed that exposure to hypoxia protected NFU1G206C rats compared to wild type. This discovery may highlight the mechanisms responsible for PH development in humans that are not exposed to hypoxic conditions. We conclude that in normoxic conditions human mutation of NFU1 reproduced in healthy rats is sufficient to induce PH and replicate the gender dimorphism seen in humans. In the presence of oxygen mitochondrial dysfunction due to NFU1 insufficiency gets synergistically potentiated by the oxidative stress.
• Rafikova, O., Srivastava, A., Desai, A. A., Rafikov, R., & Tofovic, S. P. (2018). Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung. Respiratory research, 19(1), 69.
  More info

  Pulmonary arterial hypertension (PAH) is a fatal disease; however, the mechanisms directly involved in triggering and the progression of PAH are not clear. Based on previous studies that demonstrated a possible role of mitochondrial dysfunction in the pathogenesis of PAH, we investigated the effects of chronic inhibition of mitochondrial function in vivo in healthy rodents.
• Rafikova, O., Williams, E. R., McBride, M. L., Zemskova, M., Srivastava, A., Nair, V., Desai, A. A., Langlais, P. R., Zemskov, E., Simon, M., Mandarino, L. J., & Rafikov, R. (2018). Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension. American journal of respiratory cell and molecular biology, 59(3), 334-345.
  More info

  Although hemolytic anemia-associated pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) are more common than the prevalence of idiopathic PAH alone, the role of hemolysis in the development of PAH is poorly characterized. We hypothesized that hemolysis independently contributes to PAH pathogenesis via endothelial barrier dysfunction with resulting perivascular edema and inflammation. Plasma samples from patients with and without PAH (both confirmed by right heart catheterization) were used to measure free hemoglobin (Hb) and its correlation with PAH severity. A sugen (50 mg/kg)/hypoxia (3 wk)/normoxia (2 wk) rat model was used to elucidate the role of free Hb/heme pathways in PAH. Human lung microvascular endothelial cells were used to study heme-mediated endothelial barrier effects. Our data indicate that patients with PAH have increased levels of free Hb in plasma that correlate with PAH severity. There is also a significant accumulation of free Hb and depletion of haptoglobin in the rat model. In rats, perivascular edema was observed at early time points concomitant with increased infiltration of inflammatory cells. Heme-induced endothelial permeability in human lung microvascular endothelial cells involved activation of the p38/HSP27 pathway. Indeed, the rat model also exhibited increased activation of p38/HSP27 during the initial phase of PH. Surprisingly, despite the increased levels of hemolysis and heme-mediated signaling, there was no heme oxygenase-1 activation. This can be explained by observed destabilization of HIF-1a during the first 2 weeks of PH regardless of hypoxic conditions. Our data suggest that hemolysis may play a significant role in PAH pathobiology.
• Langlais, P., Mandarino, L. J., Williams, E. R., Rafikova, O., Rafikov, R., Mcbride, M. L., Mandarino, L. J., & Langlais, P. R. (2017). Abstract 18659: Inositol Monophosphatase 1 (IMPA1) and RAGE Interaction: The Role of a Novel Proliferative Pathway in Pulmonary Hypertension. Circulation.
  More info

  Introduction: Pulmonary arterial hypertension (PAH) is a disease with high mortality and limited therapeutic options. It is characterized by a progressive pulmonary vascular remodeling, although th...
• Rafikova, O., & Rafikov, R. (2017). Pulmonary arterial hypertension: are we close to the success?. Journal of clinical respiratory medicine, 1(1), 1-2.
• Sakipov, S., Rafikova, O., Kurnikova, M. G., & Rafikov, R. (2017). Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin. Redox biology, 11, 516-523.
  More info

  Red blood cell hemolysis in sickle cell disease (SCD) releases free hemoglobin. Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability. We propose an approach that helps to eliminate extracellular hemoglobin toxicity in SCD by employing a bacterial protein system that evolved to extract heme from extracellular hemoglobin. NEAr heme Transporter (NEAT) domains from iron-regulated surface determinant proteins from Staphylococcus aureus specifically bind free heme as well as facilitate its extraction from hemoglobin. We demonstrate that a purified NEAT domain fused with human haptoglobin β-chain is able to remove heme from hemoglobin and reduce heme content and peroxidase activity of hemoglobin. We further use molecular dynamics (MD) simulations to resolve molecular pathway of heme transfer from hemoglobin to NEAT, and to elucidate molecular mechanism of such heme transferring process. Our study is the first of its kind, in which simulations are employed to characterize the process of heme leaving hemoglobin and subsequent rebinding with a NEAT domain. Our MD results highlight important amino acid residues that facilitate heme transfer and will guide further studies for the selection of best NEAT candidate to attenuate free hemoglobin toxicity.
• Zemskov, E. A., Mandarino, L. J., Langlais, P., Desai, A. A., Zemskov, E. A., Williams, E. R., Rafikova, O., Rafikov, R., Mcbride, M. L., Mandarino, L. J., Langlais, P. R., & Desai, A. A. (2017). Abstract 14565: Hemolysis-mediated Lung Vascular Permeability Contributes to the Development of Pulmonary Hypertension. Circulation.
  More info

  Introduction: There is a great disparity between the prevalence of Pulmonary Arterial Hypertension (PAH) in the general population (0.005%) and patients with hemolytic anemias: up to 32% in sickle ...
• Zhi, W. B., Wang, Y., Verin, A. D., She, J. X., Rafikova, O., Rafikov, R., Pillich, H., Lucas, R., Kumar, S., Haigh, S., Fulton, D. J., Doulias, P. T., Doulias, D., Chen, F., Chakraborty, T., Catravas, J. D., & Black, S. M. (2017). RhoA S-nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G+-bacterial toxins.. Biochemical pharmacology, 127, 34-45. doi:10.1016/j.bcp.2016.12.014
  More info

  Disruption of the endothelial barrier in response to Gram positive (G+) bacterial toxins is a major complication of acute lung injury (ALI) and can be further aggravated by antibiotics which stimulate toxin release. The integrity of the pulmonary endothelial barrier is mediated by the balance of disruptive forces such as the small GTPase RhoA, and protective forces including endothelium-derived nitric oxide (NO). How NO protects against the barrier dysfunction is incompletely understood and our goal was to determine whether NO and S-nitrosylation can modulate RhoA activity and whether this mechanism is important for G+ toxin-induced microvascular permeability. We found that the G+ toxin listeriolysin-O (LLO) increased RhoA activity and that NO and S-NO donors inhibit RhoA activity. RhoA was robustly S-nitrosylated as determined by biotin-switch and mercury column analysis. MS revealed that three primary cysteine residues are S-nitrosylated including cys16, cys20 and cys159. Mutation of these residues to serine diminished S-nitrosylation to endogenous NO and mutant RhoA was less sensitive to inhibition by S-NO. G+-toxins stimulated the denitrosylation of RhoA which was not mediated by S-nitrosoglutathione reductase (GSNOR), thioredoxin (TRX) or thiol-dependent enzyme activity but was instead stimulated directly by elevated calcium levels. Calcium-promoted the direct denitrosylation of WT but not mutant RhoA and mutant RhoA adenovirus was more effective than WT in disrupting the barrier integrity of human lung microvascular endothelial cells. In conclusion, we reveal a novel mechanism by which NO and S-nitrosylation reduces RhoA activity which may be of significance in the management of pulmonary endothelial permeability induced by G+-toxins.
• Chen, F., Wang, Y., Rafikov, R., Haigh, S., Zhi, W. B., Kumar, S., Doulias, P. T., Rafikova, O., Pillich, H., Chakraborty, T., Lucas, R., Verin, A. D., Catravas, J. D., She, J. X., Black, S. M., & Fulton, D. J. (2016). RhoA S-nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G(+)-bacterial toxins. Biochemical pharmacology.
  More info

  Disruption of the endothelial barrier in response to Gram positive (G(+)) bacterial toxins is a major complication of acute lung injury (ALI) and can be further aggravated by antibiotics which stimulate toxin release. The integrity of the pulmonary endothelial barrier is mediated by the balance of disruptive forces such as the small GTPase RhoA, and protective forces including endothelium-derived nitric oxide (NO). How NO protects against the barrier dysfunction is incompletely understood and our goal was to determine whether NO and S-nitrosylation can modulate RhoA activity and whether this mechanism is important for G(+) toxin-induced microvascular permeability. We found that the G(+) toxin listeriolysin-O (LLO) increased RhoA activity and that NO and S-NO donors inhibit RhoA activity. RhoA was robustly S-nitrosylated as determined by biotin-switch and mercury column analysis. MS revealed that three primary cysteine residues are S-nitrosylated including cys16, cys20 and cys159. Mutation of these residues to serine diminished S-nitrosylation to endogenous NO and mutant RhoA was less sensitive to inhibition by S-NO. G(+)-toxins stimulated the denitrosylation of RhoA which was not mediated by S-nitrosoglutathione reductase (GSNOR), thioredoxin (TRX) or thiol-dependent enzyme activity but was instead stimulated directly by elevated calcium levels. Calcium-promoted the direct denitrosylation of WT but not mutant RhoA and mutant RhoA adenovirus was more effective than WT in disrupting the barrier integrity of human lung microvascular endothelial cells. In conclusion, we reveal a novel mechanism by which NO and S-nitrosylation reduces RhoA activity which may be of significance in the management of pulmonary endothelial permeability induced by G(+)-toxins.
• Rafikova, O., Meadows, M. L., Kinchen, J. M., Mohney, R. P., Maltepe, E., Desai, A. A., Yuan, J. X., Garcia, J. G., Fineman, J. R., Rafikov, R., & Black, S. M. (2016). Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung. PloS one, 11(3), e0150480.
  More info

  There is increasing interest in the potential for metabolic profiling to evaluate the progression of pulmonary hypertension (PH). However, a detailed analysis of the metabolic changes in lungs at the early stage of PH, characterized by increased pulmonary artery pressure but prior to the development of right ventricle hypertrophy and failure, is lacking in a preclinical animal model of PH. Thus, we undertook a study using rats 14 days after exposure to monocrotaline (MCT), to determine whether we could identify early stage metabolic changes prior to the manifestation of developed PH. We observed changes in multiple pathways associated with the development of PH, including activated glycolysis, increased markers of proliferation, disruptions in carnitine homeostasis, increased inflammatory and fibrosis biomarkers, and a reduction in glutathione biosynthesis. Further, our global metabolic profile data compare favorably with prior work carried out in humans with PH. We conclude that despite the MCT-model not recapitulating all the structural changes associated with humans with advanced PH, including endothelial cell proliferation and the formation of plexiform lesions, it is very similar at a metabolic level. Thus, we suggest that despite its limitations it can still serve as a useful preclinical model for the study of PH.
• Rafikova, O., Rafikov, R., Kangath, A., Qu, N., Aggarwal, S., Sharma, S., Desai, J., Fields, T., Ludewig, B., Yuan, J. X., Jonigk, D., & Black, S. M. (2016). Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension. Free radical biology & medicine, 95, 96-111.
  More info

  The development of pulmonary hypertension (PH) involves the uncontrolled proliferation of pulmonary smooth muscle cells via increased growth factor receptor signaling. However, the role of epidermal growth factor receptor (EGFR) signaling is controversial, as humans with advanced PH exhibit no changes in EGFR protein levels and purpose of the present study was to determine whether there are post-translational mechanisms that enhance EGFR signaling in PH. The EGFR inhibitor, gefinitib, significantly attenuated EGFR signaling and prevented the development of PH in monocrotaline (MCT)-exposed rats, confirming the contribution of EGFR activation in MCT induced PH. There was an early MCT-mediated increase in hydrogen peroxide, which correlated with the binding of the active metabolite of MCT, monocrotaline pyrrole, to catalase Cys377, disrupting its multimeric structure. This early oxidative stress was responsible for the oxidation of EGFR and the formation of sodium dodecyl sulfate (SDS) stable EGFR dimers through dityrosine cross-linking. These cross-linked dimers exhibited increased EGFR autophosphorylation and signaling. The activation of EGFR signaling did not correlate with pp60(src) dependent Y845 phosphorylation or EGFR ligand expression. Importantly, the analysis of patients with advanced PH revealed the same enhancement of EGFR autophosphorylation and covalent dimer formation in pulmonary arteries, while total EGFR protein levels were unchanged. As in the MCT exposed rat model, the activation of EGFR in human samples was independent of pp60(src) phosphorylation site and ligand expression. This study provides a novel molecular mechanism of oxidative stress stimulated covalent EGFR dimerization via tyrosine dimerization that contributes into development of PH.
• Rafikov, R., Sun, X., Rafikova, O., Meadows, M. L., Desai, A. A., Khalpey, Z., Yuan, J. X., Fineman, J. R., & Black, S. M. (2015). Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells. Redox biology, 6, 278-86.
  More info

  ATP is essential for cellular function and is usually produced through oxidative phosphorylation. However, mitochondrial dysfunction is now being recognized as an important contributing factor in the development cardiovascular diseases, such as pulmonary hypertension (PH). In PH there is a metabolic change from oxidative phosphorylation to mainly glycolysis for energy production. However, the mechanisms underlying this glycolytic switch are only poorly understood. In particular the role of the respiratory Complexes in the mitochondrial dysfunction associated with PH is unresolved and was the focus of our investigations. We report that smooth muscle cells isolated from the pulmonary vessels of rats with PH (PH-PASMC), induced by a single injection of monocrotaline, have attenuated mitochondrial function and enhanced glycolysis. Further, utilizing a novel live cell assay, we were able to demonstrate that the mitochondrial dysfunction in PH-PASMC correlates with deficiencies in the activities of Complexes I-III. Further, we observed that there was an increase in mitochondrial reactive oxygen species generation and mitochondrial membrane potential in the PASMC isolated from rats with PH. We further found that the defect in Complex I activity was due to a loss of Complex I assembly, although the assembly of Complexes II and III were both maintained. Thus, we conclude that loss of Complex I assembly may be involved in the switch of energy metabolism in smooth muscle cells to glycolysis and that maintaining Complex I activity may be a potential therapeutic target for the treatment of PH.
• Rafikova, O., Rafikov, R., Meadows, M. L., Kangath, A., Jonigk, D., & Black, S. M. (2015). The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype. Pulmonary circulation, 5(1), 184-97.
  More info

  Although female predominance in the development of all types of pulmonary hypertension (PH) is well established, many clinical studies have confirmed that females have better prognosis and higher survival rate than males. There is no clear explanation of why sex influences the pathogenesis and progression of PH. Using a rat angioproliferative model of PH, which closely resembles the primary pathological changes observed in humans, we evaluated the role of sex in the development and progression of PH. Female rats had a more pronounced increase in medial thickness in the small pulmonary arteries. However, the infiltration of small pulmonary arteries by inflammatory cells was found only in male rats, and this corresponded to increased myeloperoxidase activity and abundant adventitial and medial fibrosis that were not present in female rats. Although the level of right ventricle (RV) peak systolic pressure was similar in both groups, the survival rate in male rats was significantly lower. Moreover, male rats presented with a more pronounced increase in RV thickness that correlated with diffuse RV fibrosis and significantly impaired right cardiac function. The reduction in fibrosis in female rats correlated with increased expression of caveolin-1 and reduced endothelial nitric oxide synthase-derived superoxide. We conclude that, in the pathogenesis of PH, female sex is associated with greater remodeling of the pulmonary arteries but greater survival. Conversely, in males, the development of pulmonary and cardiac fibrosis leads to early and severe RV failure, and this may be an important reason for the lower survival rate among males.
• Sun, X., Desai, A. A., Yuan, J. X., Sun, X., Rafkov, R., Rafikova, O., Meadows, M. L., Desai, A. A., & Black, S. M. (2015). 313 - Complex I Dysfunction Dictates Glycolytic Switch in Pulmonary Hypertensive Smooth Muscle Cells. Free Radical Biology and Medicine, 87, S140. doi:10.1016/j.freeradbiomed.2015.10.363

Proceedings Publications

• Niihori, M., Varghese, M. V., Rafikova, O., Rafikov, R., Niihori, M., Kurdyukov, S., & Eccles, C. A. (2019). Antioxidant Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension. In D16. EVERY CELL YOU BREAK: HOW CELLULAR PHENOTYPES CONTRIBUTE TO PAH.
• Niihori, M., Vasilyev, M., Rafikova, O., Rafikov, R., Niihori, M., & Eccles, C. A. (2019). Pulmonary Hypertension and Metabolic Disease in Rats with Human Mutation in Fe-S Cluster Scaffold Protein NFU1. In D16. EVERY CELL YOU BREAK: HOW CELLULAR PHENOTYPES CONTRIBUTE TO PAH.

Presentations

• Rafikov, R., Rafikova, O., Niihori, M., Zemskova, M., Eccles, C., & Kurdyukov, S. (2018, Nov). Pulmonary hypertension in rats with human mutation of NFU1 is oxygen sensitive. Society for redox biology and medicine. Chicago, IL.
• Rafikova, O. (2015, November). Reductive stress associated with male gender contributes to the pulmonary hypertension and right ventricle dysfunction.. SFRBM meeting, Boston MA.

Poster Presentations

• Rafikov, R., Rafikova, O., Langlais, P. R., Zemskova, M., Niihori, M., Varghese, M. V., & James, J. (2020, May/Summer). The NFU1 G206C mutation metabolically reprograms pulmonary artery smooth muscle cells, promotes proliferation and apoptosis resistance. American Thoracic Society.
• James, J., Zemskova, M., Eccles, C. A., Varghese, M. V., Niihori, M., Barker, N. K., Langlais, P. R., Rafikova, O., & Rafikov, R. (2019, Novermber/Fall). A single mutation in NFU1 metabolically reprograms pulmonary artery smooth muscle cells and drives proliferation with apoptosis resistance. The Society for Redox Biology and Medicine's 26th Annual Conference.
• Rafikov, R., McClain, N., Zemskova, M., James, J., & Rafikova, O. (2019, Nov). Distinct HMGB1 signaling induced by endothelial or smooth muscle pulmonary vascular cells. 9th International DAMPs and Alarmins Symposium.
• Rafikov, R., Niihiri, M., Eccles, C. A., & Rafikova, O. (2019, June). Altered pulmonary vasculature development, reticulocyte maturation and increased hemolysis in PH model of severe mitochondrial dysfunction. The Grover Conference - American Thoracic Society.
• Rafikov, R., Zemskova, M., Kurdyukov, S., McClain, N., & Rafikova, O. (2019, Nov). Sex difference in the type of cell death predispose males to increased HMGB1 release and signaling. 9th International DAMPs and Alarmins Symposium.
• McBride, M. L., McBride, M. L., Langlais, P. R., Langlais, P. R., Rafikov, R., Rafikov, R., Rafikova, O., & Rafikova, O. (2018, May). Receptor for Advanced Glycation Endproducts (RAGE) regulates metabolic reprogramming induced over-proliferation in pulmonary hypertension. American Thoracic Society.
  More info

  Our data indicate that PH patients have increased levels of free Hb in plasma that correlate with disease severity and progression. There is also a significant accumulation of free Hb and depletion of haptoglobin in the sugen/hypoxia rat model. In rats, perivascular edema was observed during first two weeks of PH concomitant with increased infiltration of inflammatory cells. In the cell culture model of HLMVECs, we found that not hemoglobin but free heme-induced endothelial permeability via activation of the p38/HSP27 signaling pathway. Indeed, the rat model also exhibited an increased activation of p38/HSP27 during the initial phase of PH. Surprisingly, despite the increased levels of hemolysis and heme-mediated signaling; there was no heme oxygenase-1 activation. This can be explained by observed destabilization of HIF1a during the first two weeks of PAH regardless of hypoxic conditions. We found that heme-mediated effects on endothelium, at least in part, depend on Heme Carrier Protein 1 (HCP-1) and pharmacological inhibition of HCP-1 by sulfasalazine reduced barrier disruptive potential of the heme. Sulfasalazine administration to sugen/hypoxia rats results in attenuation of PH by a reduction in vascular remodeling in the lungs as well as decreasing right heart hypertrophy.
• Rafikov, R., Rafikova, O., Langlais, P. R., Vasylev, M., Eccles, C., & Tofovic, S. (2018, Nov). Inhibition of respiratory chain Complex III irreversibly changes the mitochondria proteomic landscape. Society for redox biology and medicine. Chicago, IL.
• Rafikov, R., Rafikova, O., Varghese, M., Eccles, C., Kurdyukov, S., & Niihori, M. (2018, May). Antioxidant conjugated peptide attenuated metabolic reprogramming in pulmonary hypertension. American Thoracic Society meeting. Dallas, TX, USA.
• Rafikova, O., Rafikov, R., & Desai, A. (2018, July). Male gender predisposes PAH patients to reductive stress and disease progression. Pulmonary Hypertension Association's 2018 International PH Conference and Scientific Sessions.
• Rafikova, O., Rafikov, R., Niihori, M., & Eccles, C. (2018, November). Rats with Human Mutation of Fe-S Cluster Scaffold Protein NFU1 Develop Pulmonary Hypertension. American Heart Association - Scientific Sessions.
• Rafikova, O., Rafikov, R., Niihori, M., Eccles, C., & Vasilyev, M. (2018, May). Pulmonary Hypertension and Metabolic Disease in Rats with Human Mutation in Fe-S Cluster Scaffold Protein NFU1. American Thoracic Society meeting.
• Rafikova, O., Rafikov, R., Rafikov, R., Rafikov, R., Mandarino, L. J., Srivastava, A., Srivastava, A., Srivastava, A., Zemskov, E., Desai, A., Desai, A., Desai, A., Langlais, P. R., Langlais, P. R., Langlais, P. R., Langlais, P. R., Desai, A., Zemskov, E., Zemskov, E., , Zemskov, E., et al. (2018, May). Free heme-mediated endothelial barrier dysfunction contributes to the development of pulmonary hypertension. American Thoracic Society.
  More info

  Our data indicate that PH patients have increased levels of free Hb in plasma that correlate with disease severity and progression. There is also a significant accumulation of free Hb and depletion of haptoglobin in the sugen/hypoxia rat model. In rats, perivascular edema was observed during first two weeks of PH concomitant with increased infiltration of inflammatory cells. In the cell culture model of HLMVECs, we found that not hemoglobin but free heme-induced endothelial permeability via activation of the p38/HSP27 signaling pathway. Indeed, the rat model also exhibited an increased activation of p38/HSP27 during the initial phase of PH. Surprisingly, despite the increased levels of hemolysis and heme-mediated signaling; there was no heme oxygenase-1 activation. This can be explained by observed destabilization of HIF1a during the first two weeks of PAH regardless of hypoxic conditions. We found that heme-mediated effects on endothelium, at least in part, depend on Heme Carrier Protein 1 (HCP-1) and pharmacological inhibition of HCP-1 by sulfasalazine reduced barrier disruptive potential of the heme. Sulfasalazine administration to sugen/hypoxia rats results in attenuation of PH by a reduction in vascular remodeling in the lungs as well as decreasing right heart hypertrophy.
• Rafikova, O., Rafikov, R., Zemskov, M., & Kurdyukov, S. (2018, July). Gender difference on the cellular level: distinct stress responses in male and female endothelial cells isolated from mouse lungs. Pulmonary Hypertension Association's 2018 International PH Conference and Scientific Sessions.
• Rafikova, O., Rafikov, R., Zemskova, M., & Sergey Kurdyukov, S. (2018, November). Isolated Pulmonary Endothelial Cells Preserve Gender Specific Sensitivity to Stress. American Heart Association - Scientific Sessions.
• Vasilyev, M., Vasilyev, M., Langlais, P. R., Langlais, P. R., Rafikova, O., Rafikova, O., Rafikov, R., & Rafikov, R. (2018, Novermber/Fall). Inhibition of respiratory chain Complex III irreversibly changes mitochondria proteomic landscape. The Society for Redox Biology and Medicine's 25th Annual Conference.
  More info

  The role of mitochondria dysfunction in the pathogenesis of pulmonary hypertension (PH) is currently well-recognized. However, the particular mechanisms and the type of mitochondrial dysfunction are still being debated. We have recently shown that chronic inhibition of oxidative phosphorylation by Antimycin A (AA) results in increased pulmonary pressure and remodeled pulmonary arteries. AA (0.35mg/kg) was given to rats three times for six days and lungs were analyzed 30 minutes (acute effect), 12 and 24 days (chronic effect) after the first AA injection. Mitochondria isolated from lungs were subjected to mass spectrometry and quantitative proteomic analysis to estimate changes in the isolated mitochondrial proteome over the course of disease development. Using a 4-fold change cutoff value for effects on protein expression, 48 mitochondrial proteins were discovered to be altered upon AA treatment, with 13 proteins exhibiting a significant difference (ANOVA). Our data indicate that using a 4-fold cutoff w distinguished between the control and 24 day groups by principal component analysis (PCA). Functional analysis of the proteome data revealed major downregulation of enzymes involved in fatty acids oxidation (ACDSB, HADH) and fatty acids transport (CPT1, ACSM5). Electron transport chain proteins showed mixed results with downregulation of Complex IV (COX1/2), altered Complex I subunits (NU4/5M) and assembly protein expression (NDUF4), and upregulation of ubiquinone biosynthesis (COQ3/7). Activation of ubiquinone biosynthesis could be explained as compensation for inhibition of mitochondrial respiration by AA. Mitochondrial machinery for importing proteins into the matrix (TIM9/10/13) was upregulated, but peptidases (LON, MPPA) that control the quality of matrix proteins were downregulated. Finally, proteins that regulate mitochondria morphology (MIRO2, PGAM5, TMM11) and degradation pathways (MIEAP, BCL2) were altered. Collectively, our data indicate that chronic inhibition of the respiratory chain for six days leads to irreversible changes in the proteomic landscape of mitochondria. These changes reprogram mitochondria to a different metabolic state and altered morphology that have been found in various models of PH and PH patients.
• McBride, M. L., McBride, M. L., Williams, E. R., Williams, E. R., Langlais, P. R., Langlais, P. R., Mandarino, L. J., Mandarino, L. J., Rafikov, R., Rafikov, R., Rafikova, O., & Rafikova, O. (2017, June). Inositol Monophosphate 1 (IMPA1) And Rage Interaction: The Role Of Novel Proliferative Pathway In Pulmonary Hypertension. American Heart Association.
  More info

  This is a very first evidence that damage induced RAGE activation is involved in protection from glycolysis-mediated osmotic stress and activation of Akt pathway in PAH by the formation of RAGE/IMPA1 complex.
• Rafikov, R., Srivastava, A., Desai, A., Langlais, P. R., Zemskov, E., Mandarino, L. J., & Rafikova, O. (2017, June). Hemolysis-mediated vascular permeability in lungs contributes to the development of pulmonary hypertension. American Heart Association.
  More info

  Our data indicate that PH patients have increased levels of free Hb in plasma that correlate with disease severity and progression. There is also a significant accumulation of free Hb and depletion of haptoglobin in the sugen/hypoxia rat model. In rats, perivascular edema was observed during first two weeks of PH concomitant with increased infiltration of inflammatory cells. In the cell culture model of HLMVECs, we found that not hemoglobin but free heme-induced endothelial permeability via activation of the p38/HSP27 signaling pathway. Indeed, the rat model also exhibited an increased activation of p38/HSP27 during the initial phase of PH. Surprisingly, despite the increased levels of hemolysis and heme-mediated signaling; there was no heme oxygenase-1 activation. This can be explained by observed destabilization of HIF1a during the first two weeks of PAH regardless of hypoxic conditions. We found that heme-mediated effects on endothelium, at least in part, depend on Heme Carrier Protein 1 (HCP-1) and pharmacological inhibition of HCP-1 by sulfasalazine reduced barrier disruptive potential of the heme. Sulfasalazine administration to sugen/hypoxia rats results in attenuation of PH by a reduction in vascular remodeling in the lungs as well as decreasing right heart hypertrophy.
• Rafikova, O. (2015, July). Akt Mediated Mitochondrial Dysfunction Involves Mitochondrial Endothelial Nitric Oxide Synthase Translocation. AHA BCVS meeting, New Orleans, LA..
• Rafikova, O. (2015, July). Pulmonary Hypertension Induced Right Ventricle Fibrosis is Associated with Male Gender. AHA BCVS meeting, New Orleans, LA.
• Rafikova, O. (2015, November). Complex I dysfunction dictates glycolytic switch in pulmonary hypertensive smooth muscle cells.. SFRBM meeting, Boston MA.
• Rafikova, O. (2015, November). Metabolic changes precede the development of pulmonary hypertension in monocrotaline model.. SFRBM meeting, Boston MA.
• Rafikova, O. (2015, November). Targeted protein protection from oxidative/nitrosative post-translational modifications using shielding peptides.. SFRBM meeting, Boston MA.